Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Click on the tabs above to learn more about the various procedures or call us to schedule a consultation
After excluding individuals with pre-existing neurodegenerative or cerebrovascular disease, the study compared 30,430 patients using GLP-1RA therapy (semaglutide or tirzepatide) with 30,430 patients prescribed other antidiabetic agentsincluding biguanides, sulfonylureas, dipeptidyl peptidase 4 inhibitors, and sodium-glucose cotransporter 2 inhibitorsusing propensity score matching to control for baseline differences
doi: 10.1093/inthealth/ihac060 9 Rodrguez-GutirrezRMontoriVM
For patients with chronic pancreatitis, individualized decision-making is appropriate, weighing potential risks against benefits in consultation with specialists
Neuroscience, 285, 281291
US$ 21.39
US$ 27.07
US$ 21.01
US$ 25.05
US$ 29.04
US$ 22.38
US$ 26.08
